KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Inventory: 2016-2024

Historic Change in Inventory for Acadia Pharmaceuticals (ACAD) over the last 9 years, with Dec 2024 value amounting to $49.5 million.

  • Acadia Pharmaceuticals' Change in Inventory fell 193.76% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 70.55%. This contributed to the annual value of $49.5 million for FY2024, which is 72.00% up from last year.
  • As of FY2024, Acadia Pharmaceuticals' Change in Inventory stood at $49.5 million, which was up 72.00% from $28.8 million recorded in FY2023.
  • Acadia Pharmaceuticals' 5-year Change in Inventory high stood at $49.5 million for FY2024, and its period low was -$2.4 million during FY2022.
  • For the 3-year period, Acadia Pharmaceuticals' Change in Inventory averaged around $25.3 million, with its median value being $28.8 million (2023).
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Change in Inventory slumped by 157.36% in 2022, and later soared by 1,292.88% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Change in Inventory (Yearly) stood at $3.3 million in 2020, then climbed by 26.81% to $4.2 million in 2021, then slumped by 157.36% to -$2.4 million in 2022, then soared by 1,292.88% to $28.8 million in 2023, then skyrocketed by 72.00% to $49.5 million in 2024.